Neuriva
TINA.org objected to unfair settlement that allows brain supplement company to continue deceiving consumers.
Neuriva
Case Name (Date)
Timmons et al. v. Reckitt Benckiser LLC and RB Health (US) LLC
25-cv-12192, N.D. Ill.
(Oct. 2025)
Product/Service
Neuriva Original, Neuriva Original Strawberry Gummies, Neuriva Plus, Neuriva Plus Strawberry Gummies, and Neuriva Ultra
Allegations
Falsely marketing that products help memory, focus, concentration, learning and accuracy when none of the ingredients provide the advertised benefits
Falsely marketing that products have been “clinically tested” to provide brain health benefits when a study performed by the company shows that they do not provide such benefits
Status
Pending
Legal Action
Class-Action Tracker
Neuriva
Allegations: Falsely marketing Neuriva supplements as “clinically proven” to improve “brain performance” when the company has no scientific or clinical proof that the supplements or ingredients in them provide the…
The Latest
CATrends: OTC Cold and Flu Meds Falsely Marketed as Nasal Decongestants
An FDA panel’s recent findings has led to a flood of lawsuits.
Researchers Call on FDA (Again) to Remove ‘Ineffective’ OTC Cold and Flu Medicines
Products marketed to clear up stuffy noses and relieve sinus congestion don’t work, researchers say.
Proposed Settlement Allows for Continued Deceptive Marketing of Neuriva
TINA.org files brief urging court to deny final approval of settlement that is unfair to consumers.
CATrends: Toddler Formula
It’s the perfect formula for a class-action lawsuit trend.
